Your browser doesn't support javascript.
loading
Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis.
Chappuis, Maëlle; Rousseau, Chloé; Bajeux, Emma; Wiertlewski, Sandrine; Laplaud, David; Le Page, Emmanuelle; Michel, Laure; Edan, Gilles; Kerbrat, Anne.
Affiliation
  • Chappuis M; Department of Neurology, University Hospital, Rennes, France. maelle.chappuis@chu-rennes.fr.
  • Rousseau C; Research Management Department, University Hospital, Rennes, France.
  • Bajeux E; Department of Epidemiology and Public Health, University Hospital, Rennes, France.
  • Wiertlewski S; Department of Neurology, University Hospital, Nantes, France.
  • Laplaud D; Department of Neurology, University Hospital, Nantes, France.
  • Le Page E; Department of Neurology, University Hospital, Rennes, France.
  • Michel L; CIC-P 1414 Inserm, University Hospital, Rennes, France.
  • Edan G; Department of Neurology, University Hospital, Rennes, France.
  • Kerbrat A; CIC-P 1414 Inserm, University Hospital, Rennes, France.
J Neurol ; 270(1): 413-422, 2023 Jan.
Article in En | MEDLINE | ID: mdl-36121558
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies Limits: Humans / Middle aged Language: En Journal: J Neurol Year: 2023 Document type: Article Affiliation country: France Country of publication: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Multiple Sclerosis, Relapsing-Remitting / Multiple Sclerosis Type of study: Prognostic_studies Limits: Humans / Middle aged Language: En Journal: J Neurol Year: 2023 Document type: Article Affiliation country: France Country of publication: Germany